GGrantIndex
Sort

326,823 grants matching clinical trial

Laboratory And Pre-clinical Studies Of Parainfluenza Viruses

$1,553,196
Peter Leon Collins · National Institute Of Allergy And Infectious Diseases · ZIA · FY2018 · AI

Biochemical Analysis of Multidrug Resistance-linked Transport Proteins

$1,553,172
Suresh Ambudkar · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA

Safety and PK Study in Hepatic Impairment Patients

$1,553,079
Weizhong Cai · Angion Biomedica Corporation · R44 · FY2010 · AA

The MW Cancer Prevention Clinical Trials Network

$1,552,933
Lisa M Barroilhet · University Of Wisconsin-Madison · UG1 · FY2024 · CA

BOTANICAL DIETARY SUPPLEMENTS FOR WOMEN'S HEALTH

$1,552,815
University Of Illinois At Chicago · P50 · FY2001 · AT

2/2-A Comparison of Long-Acting Injectable Medications for Schizophrenia -ACLAIMS

$1,552,797
Thomas Scott Stroup · Columbia University Health Sciences · R01 · FY2009 · MH

IL-2:IL-15 cytokine receptor: implications for cancer therapy and vaccine

$1,552,630
Thomas Waldmann · Division Of Clinical Sciences - Nci · ZIA · FY2019 · CA

Mitigation of the Catecholamine Surge in Severely Burned Patients

$1,552,622
David N Herndon · University Of Texas Med Br Galveston · P50 · FY2014 · GM

Colaboracion Evita: HPV-Related Cancer Prevention Partnership Center

$1,552,556
Margaret M Madeleine · Fred Hutchinson Cancer Center · U54 · FY2024 · CA

Development of a small-molecule that enhances tripartite synapses for Alzheimers disease

$1,552,548
Chien-Liang Glenn Lin · Ohio State University · U01 · FY2020 · AG

Targeting Cell Signaling in lung cancer to enhance therapeutic efficacy

$1,552,534
Fadlo Raja Khuri · Emory University · P01 · FY2010 · CA

Novel Therapeutics for FSHD

$1,552,437
Charles P Emerson · Univ Of Massachusetts Med Sch Worcester · P50 · FY2019 · HD

IGF::OT::IGF Task Order No. 2 - "van Leyen MCSP-EC"

$1,552,302
Keith Barnes · Albany Molecular Research, Inc. · N01 · FY2020 · DA

TAS::75 0849::TAS INCREMENTAL FUNDING

$1,552,160
David Heimbrook · Leidos Biomedical Research, Inc. · N01 · FY2011 · CA

Dissecting the mechanisms of HIV resistance in vivo to broadly neutralizing antibodies

$1,552,089
Alon Herschhorn · University Of Minnesota · U01 · FY2023 · AI

Immune determinants of pediatric HIV/SIV reservoir establishment and maintenance

$1,552,021
Ann M Chahroudi · Emory University · P01 · FY2025 · HD

Consortium for the Study of Chronic Pancreatitis, Diabetes and Pancreatic Cancer: Coordinating and Data Management Center (CSCPDPC-CDMC)

$1,552,014
Ziding Feng · University Of Tx Md Anderson Can Ctr · U01 · FY2017 · DK

Genetics, Pathophysiology, and Treatment of Recessive Autoinflammatory Diseases

$1,551,984
Daniel Kastner · National Human Genome Research Institute · ZIA · FY2023 · HG

SCOR IN SUDDEN CARDIAC DEATH

$1,551,922
University Of Utah · P50 · FY2004 · HL

NATIONAL DRUG ABUSE TREATMENT CLINICAL TRIALS NETWORK

$1,551,803
Duke University · U10 · FY2003 · DA

Direct and Repeated Clinical Measurement of pO2 for Enhancing Cancer Therapy

$1,551,754
Harold M Swartz · Dartmouth College · P01 · FY2015 · CA

Storage and Distribution of Clinical Agents

$1,551,575
Young Kim · Fisher Bioservices, Inc. · N02 · FY2010 · CA

Dynamic Outcome Assessment in Multi Center Trials(RMI)

$1,551,374
Duke University · U01 · FY2005 · AR

Locus of Care &Pressure Ulcers After Hip Fracture

$1,551,333
University Of Maryland Baltimore · R01 · FY2003 · AR

Stanford Diabetes Research Center

$1,551,177
Seung K Kim · Stanford University · P30 · FY2018 · DK